Scinai Immunotherapeutics Ltd. Share Price
Stocks
SCNI
US09073Q4029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 06/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.260 USD | -5.26% |
|
-18.71% | -82.31% |
| 26/08 | Scinai Immunotherapeutics Ltd., H1 2026 Earnings Call, Aug 26, 2026 | |
| 24/08 | Scinai Immunotherapeutics Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 8L 7L 6L 6L 10.8L 7.3Cr 10.87L 76.06L 29.57L 3.72Cr 28.46L 27.84L 12Cr | P/E 2024 * |
-
| P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 13.64L 12.16L 11.33L 10.32L 19.44L 13Cr 19.56L 1.37Cr 53.2L 6.7Cr 51.21L 50.1L 22Cr | EV / Sales 2024 |
45,21,658x | EV / Sales 2025 | 23,46,086x |
| Free-Float |
0.36% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SCNI | Delayed | |
CBOE
| SCNI | Real-time | |
|
Deutsche Boerse AG
| 2F50 | Delayed |
Last Transcript: Scinai Immunotherapeutics Ltd.
| 1 day | -5.26% | ||
| 1 week | -18.71% | ||
| Current month | -11.27% | ||
| 1 month | -32.26% | ||
| 3 months | -53.40% | ||
| 6 months | -79.00% | ||
| Current year | -82.31% |
| 1 week | 1.26 |  | 1.5 |
| 1 month | 1.26 | | 2.67 |
| Current year | 1.26 | | 11.2 |
| 1 year | 1.26 | | 16.3 |
| 3 years | 1.26 | | 89.2 |
| 5 years | 1.26 | | 3,490 |
| 10 years | 1.26 | | 61,999.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir Reichman
CEO | Chief Executive Officer | 51 | 02/03/2021 |
Uri Ben-Or
DFI | Director of Finance/CFO | 55 | 01/01/2007 |
Dalit Fischer
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Germain
CHM | Chairman | 77 | 30/09/2019 |
Samuel Moed
BRD | Director/Board Member | 64 | 24/03/2020 |
Adi Raviv
BRD | Director/Board Member | 71 | 24/03/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/03/26 | Other | Chief Financial Officer | 3,58,48,348 | 1.0507% | ||
| 18/03/26 | Other | Director | 5,74,00,000 | 1.6823% | ||
| 18/03/26 | Other | Director | 6,04,00,000 | 1.7702% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.26% | -18.71% | -90.53% | -98.32% | 8L | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.42TCr | |
| -0.37% | -3.88% | +19.75% | +78.35% | 5.74TCr | |
| +1.63% | +0.98% | +3.83% | +38.21% | 4.76TCr | |
| +0.50% | +1.32% | +344.62% | +753.25% | 4.43TCr | |
| +3.05% | -1.58% | +28.78% | +35.46% | 4.25TCr | |
| +1.00% | +0.22% | +5.17% | +113.80% | 4.07TCr | |
| -0.54% | +2.93% | +9.31% | +54.06% | 3.1TCr | |
| +1.56% | +4.53% | +31.34% | +26.92% | 2.85TCr | |
| +0.76% | -0.89% | -7.44% | -11.43% | 2.43TCr | |
| Average | +0.65% | -1.95% | +39.42% | +108.45% | 3.91TCr | |
| Weighted average by Cap. | +1.55% | -0.84% | +58.06% | +140.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.66 0.59 0.55 0.5 0.94 63.37 0.94 6.6 2.57 32.31 2.47 2.42 103.88 | 1.31 1.17 1.09 0.99 1.87 126.25 1.88 13.15 5.11 64.38 4.92 4.81 206.98 |
| Net income | 47.96L 42.74L 39.84L 36.27L 68.35L 46Cr 68.79L 4.81Cr 1.87Cr 24Cr 1.8Cr 1.76Cr 76Cr | -83.07L -74.03L -69.01L -62.82L -1.18Cr -80Cr -1.19Cr -8.33Cr -3.24Cr -41Cr -3.12Cr -3.05Cr -131.15Cr |
| Net Debt | 1L 1L 1L 92.26T 2L 1.17Cr 2L 12.24L 5L 59.91L 5L 4L 1.93Cr | 6L 5L 5L 5L 9L 5.84Cr 9L 60.8L 23.63L 2.98Cr 22.75L 22.26L 9.57Cr |
Employees
45
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | $1.260 | -5.26% | 33,518 |
| 02/26/02 | $1.330 | +1.53% | 22,168 |
| 01/26/01 | $1.310 | -7.75% | 43,751 |
| 30/26/30 | $1.420 | +0.71% | 80,134 |
| 29/26/29 | $1.410 | -4.08% | 98,629 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCNI Stock
Select your edition
All financial news and data tailored to specific country editions
